The Engage Therapeutics brand, founded in 2017 (United States), from 359 sister brands and 2214 competing brands. The Engage Therapeutics brand is owned by UCB, a company listed in Bruxelles. The ISIN, the company's International Securities Identification Number, is BE0003739530. Engage Therapeutics belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
UCB
(Engage Therapeutics)
over 5 years*
EUR 203.05